Long-term Follow Up of a Prospective Multicenter Trial with a High-Dose Cytosine Arabinoside and Daunorubicin Postremission Therapy in Adults with De Novo Acute Myeloid Leukemia

Gerhard Heil; Paris S. Mitrou; D. Hoelzer; Mathias Freund; H. Link; Gerhard Ehninger; B. Steinke; S. Öhl; H. Wandt; E. Fackler-Schwalbe; Günter Schlimok; A Lösch; W. Queißer; B. Löffler; Wilhelm Gaus; Josef Högel; H. Heimpel; E. Kurrle

doi:10.1007/978-3-642-60377-8_126

BOOK-CHAPTER

Long-term Follow Up of a Prospective Multicenter Trial with a High-Dose Cytosine Arabinoside and Daunorubicin Postremission Therapy in Adults with De Novo Acute Myeloid Leukemia

Gerhard Heil Paris S. Mitrou D. Hoelzer Mathias Freund H. Link Gerhard Ehninger B. Steinke S. Öhl H. Wandt E. Fackler-Schwalbe Günter Schlimok A Lösch W. Queißer B. Löffler Wilhelm Gaus Josef Högel H. Heimpel E. Kurrle

Year: 1997 Hämatologie und Bluttransfusion Pages: 824-830 Publisher: Springer Nature

DOI: 10.1007/978-3-642-60377-8_126

Get Full-Text PDF Get Analytical Report

Keywords:

Medicine Daunorubicin Etoposide Internal medicine Gastroenterology Myeloid leukemia Cytarabine Surgery Confidence interval Prospective cohort study Leukemia Chemotherapy

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.28

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Acute Myeloid Leukemia Research

Health Sciences → Medicine → Hematology

Histone Deacetylase Inhibitors Research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Acute Lymphoblastic Leukemia research

Health Sciences → Medicine → Public Health, Environmental and Occupational Health

Related Documents

JOURNAL ARTICLE

High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia Long-term follow-up of a prospective multicenter trial

Gerhard Heil P.S. Mitrou D. Hoelzer Mathias Freund H. Link G. Ehninger B. Steinke S. �hl H. Wandt E. Fackler-Schwalbe Günter Schlimok A. L�sch W. Quei�er B. L�ffler Wilhelm Gaus J. H�gel H. Heimpel E. Kurrle

Journal: Annals of Hematology Year: 1995 Vol: 71 (5)Pages: 219-225

JOURNAL ARTICLE

High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia

Gerhard Heil Paris S. Mitrou D. Hoelzer Mathias Freund H. Link Gerhard Ehninger B. Steinke S. Öhl H. Wandt E. Fackler-Schwalbe G. Schlimok A Lösch W. Queißer B. Löffler W. Gaus Josef Högel H. Heimpel E. Kurrle

Journal: Annals of Hematology Year: 1995 Vol: 71 (5)Pages: 219-225

BOOK-CHAPTER

Aclarubicin Plus Cytosine Arabinoside Versus Daunorubicin plus Cytosine Arabinoside in De Novo Acute Myelocytic Leukemia: A Danish National Trial

Ole Hansen J. Ellegaard P Bastrup-Madsen H Brincker Bjarne Christensen Sven-Åge Killmann M. L. Lauersen H Karle A Drivsholm MK Jensen Birgitte Schantz Laursen H Jans Erik Hippe J. Petersen-Bjergaard Neel I. Nissen K Thorling K B Jensen

Year: 1990 Pages: 19-20

JOURNAL ARTICLE

Antiemetic Therapy in Patients Treated with High-Dose Cytosine Arabinoside

John B. Craig Bayard L. Powell Dougľas R. White Robert L. Capizzi

Journal: Oncology Year: 1987 Vol: 44 (2)Pages: 90-92

JOURNAL ARTICLE

Cerebellar toxicity with high-dose cytosine arabinoside.

R H Herzig John Hines Geoffrey P. Herzig Steven N. Wolff Peter A. Cassileth Hillard M. Lazarus David J. Adelstein R.A. Brown Peter F. Coccia Sarah E. Strandjord

Journal: Journal of Clinical Oncology Year: 1987 Vol: 5 (6)Pages: 927-932